I.G. Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

I.G. Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.6M	Hold	10,500	–	–	0.01%	262
2017 Q2	$1.35M	Sell	10,500 -4,600	-30%	-$554K	0.01%	300
2017 Q1	$1.65M	Sell	15,100 -900	-6%	-$79.2K	0.01%	279
2016 Q4	$1.18M	Sell	16,000 -39,515	-71%	-$3.22M	0.01%	308
2016 Q3	$4.84M	Sell	55,515 -35,893	-39%	-$3.39M	0.02%	392
2016 Q2	$7.86M	Buy	91,408 +59,089	+183%	+$5.11M	0.03%	298
2016 Q1	$2.57M	Sell	32,319 -3,410	-10%	-$308K	0.01%	471
2015 Q4	$4.5M	Sell	35,729 -20,169	-36%	-$2.43M	0.02%	359
2015 Q3	$5.82M	Buy	55,898 +13,154	+31%	+$1.69M	0.02%	305
2015 Q2	$5.28M	Sell	42,744 -2,356	-5%	-$297K	0.02%	346
2015 Q1	$5.32M	Sell	45,100 -6,257	-12%	-$750K	0.02%	347
2014 Q4	$6.1M	Sell	51,357 -3,472	-6%	-$391K	0.02%	318
2014 Q3	$6.16M	Buy	54,829 +20,431	+59%	+$1.95M	0.02%	303
2014 Q2	$3.26M	Buy	34,398 +345	+1%	+$24.2K	0.01%	401
2014 Q1	$2.41M	Sell	34,053 -9,500	-22%	-$752K	0.01%	420
2013 Q4	$3.24M	Sell	43,553 -9,000	-17%	-$627K	0.01%	387
2013 Q3	$3.98M	Buy	52,553 +12,400	+31%	+$987K	0.02%	356
2013 Q2	$3.21M	Buy	+40,153	New	+$2.96M	0.01%	388

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

I.G. Investment Management's VRTX Position: Q3 2017 in Review

I.G. Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2017 at 10,500 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #262.

I.G. Investment Management first reported a position in VRTX in Q2 2013 and has held it in 18 quarters since. The position peaked at $7.86M in Q2 2016. 611 funds tracked by Wall St. Rank hold VRTX as of Q3 2017.

I.G. Investment Management held 10,500 shares of Vertex Pharmaceuticals worth $1.6M as of Q3 2017.
I.G. Investment Management left its Vertex Pharmaceuticals share count unchanged in Q3 2017.
Vertex Pharmaceuticals made up 0.01% of I.G. Investment Management's portfolio in Q3 2017, its #262 holding.
I.G. Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
I.G. Investment Management's Vertex Pharmaceuticals position peaked at $7.86M in Q2 2016.
611 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2017.

Based on I.G. Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.